Complex coronary cases
PCI of Unprotected LM Coronary Artery – Sept 2011

2

Case: 68-year old male with prior PCI’s in 1999, has crescendo angina and high risk stress MPI for multi-vessel ischemia. Cardiac cath revealed calcified distal left main with circumflex disease (Syntax Score 16) and moderate LV dysfunction (LVEF 40%). Now planned for PCI of unprotected left main coronary artery.

1:05:35

Q&A
Q
In this particular case with unprotected LMCA, where do you see the roles for IVUS, FFR and OCT?
A.

IVUS is better suited for post DES optimization; FFR for ambiguous intermediate lesions; OCT as a research tool only.


Q
Which one will you find most useful here?
A.

IVUS particularly for stent optimization; that is what we did.


Q
For low SYNTAX, is PCI your first choice at your institution? What % of your PCI are unprotected LMCA?
A.

Yes for Syntax score <33 PCI is our first choice and we even do not call our CT surgeons for consultation. If Syntax score >32, then a CT surgery consultation is must and if pt still refuses, then only PCI can be contemplated. Yes there are some exceptions to this policy such as AMI, severe COPD , age >80yrs and h/o CVA. Unprotected LM PCI cases now are about 25 of 425 PCIs (approx. 6%) per month.


Q
In what % unprotected vLMCA are you using IVUS and in what particular situations?
A.

We use IVUS in about 20% of Unprotected LM PCI; especially in cases of haziness and r/o any edge dissections.


Q
Not using a support device these days for unsupported LMCA?
A.

About 8-10% of Unprotected LM PCIs are done with support device; especially one with LVEF <25% and one requiring Rotational atherectomy.


Q
For unprotected LMCA, should platelet reactivity studies be always performed?
A.

Makes perfect sense to know that platelet inhibition if optimal in these high risk cases especially if on Clopidogrel. I do check platelet reactivity in unprotected LM DES cases and then tailor the antiplatelet therapy based on the PRU data.


Q
Which anti-platelet will you prefer for unprotected LMCA – Clopidogrel, Prasugrel or Ticagrelor? Why?
A.

If age/CVA are not the issues, I will prefer 5mg daily dose of prasugrel; because of its reliable consistent platelet inhibition. We don’t have experience with Ticagrelor yet, but I guess it could a preferred agent in cases with high risk for bleeding.


Q
In your elective PCI, are you always using high dose statins?
A.

Not routinely but data do support giving Atorvastatin 80 mg 12-24hrs prior to elective PCI in reducing the post-procedure MI. This has been incorporated in the EXCEL trial of Left main Intervention.


Q
Which DES are you finding particularly beneficial for LMCA?
A.

Now EES type DES of Xience V or Promus is the preferred DES for uLM PCI.


Q
What do you feel will be the most critical message from the EXCEL trial?
A.

To show that DES PCI will be as good as CABG or may even has a chance to be better, in low-intermediate Syntax score.


comments

Leave a Reply

Your email address will not be published. Required fields are marked *

suggestion
Suggestions
Staged PCI of RCA multilayer DES CTO ISR using rotational atherectomy and IVBT – November 2020
Views 266

Case and Plan: 65-year old male with known long standing history of chronic ischemic heart disease requiring multiple PCI’s over the years after declining CABG, presented with CCS Class III angina and high risk stress MPI for multivessel ischemia. A Cardiac Cath on September 28, 2020 revealed 3 V CAD: 100% proximal RCA due to […]


Complex Multivessel PCI in a High SYNTAX Score Patient – October 2020
Tags: | |
Views 346

Case and Plan: 74-year-old obese male on HD presented with CCS Class II angina and positive SPECT MPI on July 14, 2020 done as pre-op for renal transplant revealing moderate apical, inferior and inferolateral ischemia. A Cardiac Cath on August 20, 2020 revealed 3 V CAD: 70% mid RCA, 100% RCA-AV Cont, subtotal calcified mid-distal […]


Radial PCI of Long Complex Calcified LAD post TAVR – September 2020
Views 270

Case and Plan: 78 year-old-male presented on August 7, 2020 with progressive exertional dyspnea, NYHA class III. Workup revealed severe AS (AVA 0.7cm2), normal LV function and STS mortality of 1.1%. After heart team discussion, patient underwent successful TAVR using 26mm SAPIEN-3 Ultra with excellent results, AV area of 2.0cm2 and no PVL. A coronary […]


Stent Ablation with RA of Underexpanded Multilayer DES – August 2020
Tags: | |
Views 442

63 year-old male with known CAD, CABG x2 (1999) and multiple PCI’s to SVG to RCA and LCx branches presented with CCS Class IV angina and non-STEMI (TnI 1.2U). A Cardiac Cath on June 22, 2020 revealed patent LIMA to LAD, non obstructive LCx branches with patent prior stents and 90% multilayer in-stent restenosis of […]